---
figid: PMC9563553__cancers-14-04835-g005
pmcid: PMC9563553
image_filename: cancers-14-04835-g005.jpg
figure_link: /pmc/articles/PMC9563553/figure/cancers-14-04835-f005/
number: Figure 5
figure_title: ''
caption: TAZ expression levels in terms of international immunoreactive score categories
  (SxP_irs_c). (A) Tumor from a patient that did not obtain pCR, showing “negative”
  nuclear and cytoplasmic expression. (B) Tumor from a patient that did not obtain
  pCR, showing “positive weak” nuclear and cytoplasmic expression. (C) Tumor from
  a patient that obtained pCR, showing “positive intermediate” nuclear and cytoplasmic
  expression. (D) Tumor from a patient that obtained pCR, showing “positive strong”
  nuclear and “positive intermediate” cytoplasmic expression.
article_title: 'The Impact of the Hippo Pathway and Cell Metabolism on Pathological
  Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter
  Prospective Study.'
citation: Eriseld Krasniqi, et al. Cancers (Basel). 2022 Oct;14(19):4835.
year: '2022'

doi: 10.3390/cancers14194835
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI

keywords:
- Hippo pathway
- cell metabolism
- Her2−positive breast cancer
- pathological complete response

---
